FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Global approvals · expansion Supplies its continuous glucose monitor to 29 countries and has applied for European certification of the next model. Also seen: Early clinical · first deals

  • Applied for European CE certification of its next continuous glucose monitor. Source

Roles often seen at this stageDevice R&D & support · Regulatory affairs · Sales & marketing

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

i-SENS

A medical-device company making blood-glucose meters and the CareSens Air continuous glucose monitor, which it supplies to 29 countries.

CareSens Air

Marketed

A continuous glucose monitor worn for 15 days, supplied to 29 countries including 13 in Europe and reimbursed in eight.

CareSens Air 2

Approved

Next-generation continuous glucose monitor with an 18-day wear time and a sensor about 70% smaller; approved in Korea, with European certification applied for.

Announced

Applied for European CE certification of the CareSens Air 2 continuous glucose monitor.

Official role guide

i-SENS careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 아이센스, '케어센스 에어 2' 유럽 CE 인증 신청 ↗뉴스핌 · Published 2026-07-13 · Sources checked 2026-11-15 · Original unavailable
  2. 아이센스, '케어센스 에어 2' 식약처 허가 완료 ↗메디파나뉴스 · Published Date unconfirmed · Sources checked 2026-11-15 · Original unavailable